Revolutionary ‘Axialtrode’ Brain Implant Promises Breakthroughs in Neurological Research and Treatment
A novel brain implant, offering unprecedented precision in both neural signal recording and targeted drug delivery, is poised to reshape our understanding of the brain and potentially revolutionize treatments for conditions like epilepsy.
Researchers from the Technical University of Denmark (DTU), the University of Copenhagen, University College London, and collaborating institutions have developed the microfluidic Axialtrode (mAxialtrode) – a long, needle-thin electrode with integrated channels. This innovative design allows for the simultaneous monitoring of brain activity across multiple layers and the precise delivery of medication to specific brain regions. The findings, published in the journal Advanced Science in July 2026, represent a significant leap forward in neurotechnology.
Addressing the Limitations of Current Brain Implants
Current brain implants often rely on rigid materials like silicon, which can cause irritation and trigger inflammatory responses within the delicate brain tissue. The mAxialtrode overcomes this challenge by utilizing soft, flexible optical fibers, minimizing damage during implantation. As one researcher emphasized, the new implant makes brain research “less invasive and more precise” by combining multiple functions into a single device.
Traditional methods for studying brain activity, such as using conventional flat-end optical fibers, are limited in their scope. These fibers primarily interact with the brain at a single point – the tip – hindering the ability to observe interactions between different brain layers. This limitation is particularly problematic given that many crucial brain functions rely on complex communication across multiple areas.
How the mAxialtrode Works
The mAxialtrode is manufactured through a precise process akin to creating sugar thread, where a polymer rod is heated and drawn into an ultra-thin fiber. A central core facilitates light conduction, while eight surrounding microscopic channels accommodate fluid delivery and thin metal wires for electrical measurements.
The resulting fiber is less than half a millimeter thick and remarkably flexible, allowing it to move with the brain rather than causing disruption. This flexibility is key to minimizing inflammatory reactions. The device’s unique design enables researchers to stimulate nerve cells with light, measure electrical activity from various brain depths – including the cerebral cortex and hippocampus – and inject substances with pinpoint accuracy, all within a three-millimeter range.
Promising Results from In Vivo Testing
The technology has already demonstrated its potential in laboratory settings and, crucially, in in vivo experiments conducted on mice. Researchers successfully stimulated nerve cells using both blue and red light, simultaneously measured electrical activity across different brain layers, and delivered targeted injections. Notably, the animals exhibited no obvious signs of discomfort during the experiments.
These in vivo studies benefited from close collaboration with Associate Professor Rune W. Berg from the University of Copenhagen and Associate Professor Rob C. Wykes from University College London, who provided expertise in neural circuit analysis and epilepsy models.
Future Implications and Clinical Trials
While the mAxialtrode holds immense promise, further development and rigorous testing are essential before it can be implemented in clinical practice. Researchers are currently working to patent the underlying technology and explore the feasibility of clinical trials.
The long-term vision extends beyond basic research. The mAxialtrode could pave the way for targeted drug delivery combined with electrical or light-based stimulation, offering new therapeutic avenues for neurological disorders. .
The researchers are optimistic about the future of this technology, believing it will unlock new insights into the complexities of the brain and ultimately improve the lives of individuals affected by neurological diseases.
Source: DTU (Technical University of Denmark)
Journal reference: Sui, K., et al. (2026). Multimodal Layer‐Crossing Interrogation of Brain Circuits Enabled by Microfluidic Axialtrodes. Advanced Science. DOI: 10.1002/advs.202519744. https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202519744
